Huiping Huang

Fuzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Optimization of oral isavuconazole dose for population in special physiological or pathological state: a physiologically based pharmacokinetics model-informed precision dosing.

Optimization of oral isavuconazole dose for population in special physiological or pathological state: a physiologically based pharmacokinetics model-informed precision dosing.

Journal: The Journal of antimicrobial chemotherapy

Published: February 03, 2024

Predicting busulfan exposure in patients undergoing hematopoietic stem cell transplantation using machine learning techniques.

Predicting busulfan exposure in patients undergoing hematopoietic stem cell transplantation using machine learning techniques.

Journal: Expert review of clinical pharmacology

Published: June 16, 2023

Population Pharmacokinetic Modeling Using Polymyxin B Free Plasma Concentrations From Published Reports and Evaluation of Dosage Regimens Based on Monte Carlo Simulation in Critically Ill Patients.

Population Pharmacokinetic Modeling Using Polymyxin B Free Plasma Concentrations From Published Reports and Evaluation of Dosage Regimens Based on Monte Carlo Simulation in Critically Ill Patients.

Journal: Journal of clinical pharmacology

Published: December 05, 2022

Two Innovative Approaches to Optimize Vancomycin Dosing Using Estimated AUC after First Dose: Validation Using Data Generated from Population PK Model Coupled with Monte-Carlo Simulation and Comparison with the First-Order PK Equation Approach.

Two Innovative Approaches to Optimize Vancomycin Dosing Using Estimated AUC after First Dose: Validation Using Data Generated from Population PK Model Coupled with Monte-Carlo Simulation and Comparison with the First-Order PK Equation Approach.

Journal: Pharmaceutics

Published: February 17, 2022

External evaluation of population pharmacokinetic models for voriconazole in Chinese adult patients with hematological malignancy.

External evaluation of population pharmacokinetic models for voriconazole in Chinese adult patients with hematological malignancy.

Journal: European journal of clinical pharmacology

Published: February 11, 2022

External Evaluation of Population Pharmacokinetic Models of Busulfan in Chinese Adult Hematopoietic Stem Cell Transplantation Recipients.

External Evaluation of Population Pharmacokinetic Models of Busulfan in Chinese Adult Hematopoietic Stem Cell Transplantation Recipients.

Journal: Frontiers in pharmacology

Published: December 14, 2021

Can Published Population Pharmacokinetic Models of Busulfan Be Used for Individualized Dosing in Chinese Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation? An External Evaluation.

Can Published Population Pharmacokinetic Models of Busulfan Be Used for Individualized Dosing in Chinese Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation? An External Evaluation.

Journal: Journal of clinical pharmacology

Published: July 14, 2021

A physiologically based pharmacokinetic analysis to predict the pharmacokinetics of intravenous isavuconazole in patients with or without hepatic impairment.

A physiologically based pharmacokinetic analysis to predict the pharmacokinetics of intravenous isavuconazole in patients with or without hepatic impairment.

Journal: Antimicrobial agents and chemotherapy

Published: February 23, 2021

Showing 1-8 of 8

Last Updated: 09/26/2026